human

InterMune Soaring 90% in Early Pre-Market on European Commit

agency, chmp, commission, committee, disease, drug, ema, esbriet, eu, european, fibrosis, human, idiopathic, intermune, ipf, itmn, lung, markets, medicinal, medicines, mild, products, pulmonary, treatment, use

InterMune (ITMN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Esbriet (pi

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Bunge Shares Sinking Lower, Down 1.7%...

One of today's stocks on the move is Bunge (NYSE:BG), down 1.7% to $70.48. The S&P is ...

Shares of Applied Micro Circuits Under P...

One of today's notable stocks in decline is Applied Micro Circuits (NASDAQ:AMCC), down ...

Resource Capital Shares Sinking Lower, D...

Resource Capital (NYSE:RSO) is one of today's notable stocks in decline, down 1.7% to $ ...

Diodes Shares Sinking Lower, Down 1.7%...

One of today's stocks on the move is Diodes (NASDAQ:DIOD), down 1.7% to $23.04. The Do ...

Shares of Arbor Realty Trust Under Press...

One of today's stocks on the move is Arbor Realty Trust (NYSE:ABR), down 1.7% to $6.91. ...

Shares of Public Storage Under Pressure,...

One of today's stocks on the move is Public Storage (NYSE:PSA), down 1.7% to $160.20. ...

Acadia Realty Trust Makes a Move: Down 1...

One of today's notable stocks in decline is Acadia Realty Trust (NYSE:AKR), down 1.7% t ...

Stock Investors Sell Off Shares of LTC P...

LTC Properties (NYSE:LTC), a company whose shares are moving quickly, is trading 1.7% l ...

Most Popular Video News